SCHEMBL829213

SCHEMBL829213

CCOC(=O)c1cc2cc(O)ccc2[nH]1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.76
▸ ALDH1A1 P00352 3/20 0.76
▸ HPGD P15428 3/20 0.76
▸ RAB9A P51151 3/20 0.76
▸ SMN1; SMN2 Q16637 2/20 0.76
▸ HSD17B10 Q99714 1/20 0.76
▸ NPC1 O15118 2/20 0.70
▸ LMNA P02545 2/20 0.70
▸ HTT P42858 1/20 0.70
▸ L3MBTL1 Q9Y468 1/20 0.70
▸ HRH3 Q9Y5N1 1/20 0.70
▸ MMP13 P45452 7/20 0.68
▸ MMP2 P08253 5/20 0.68
▸ GAA P10253 2/20 0.65
▸ MEN1 O00255 1/20 0.65
▸ GLA P06280 1/20 0.65
▸ MAPT P10636 1/20 0.65
▸ KMT2A Q03164 1/20 0.65
▸ ATM Q13315 1/20 0.65
▸ MMP14 P50281 3/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907791 0.88 ALOX15 (0.72) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL85706 0.86 RAB9A (1.00) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL30994860 0.86 RAB9A (1.00) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL829242 0.85 KDM4E (0.76) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL68923 0.85 HRH3 (0.84) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL656018 0.84 KDM4E (0.74) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL14647683 0.84 KDM4E (0.74) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL31435632 0.84 KDM4E (0.74) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL333895 0.84 KDM4E (0.74) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL31058816 0.84 KDM4E (0.74) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115701440-A Polyimide composite film, preparation method thereof and electronic equipment 华为技术有限公司 2023-02-10 — — CN claimed
CN-113150189-A Preparation method of benzophenone photoinitiator 优缔贸易(上海)有限公司 2021-07-23 — — CN claimed
EP-2948454-B1 TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENT & IND RES AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGISTRATION OF SOCIETI (IN) 2017-05-31 — — EP claimed
US-9447105-B2 Triazine compounds and a process for preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-09-20 — — US claimed
US-20150353566-A1 TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-12-10 — — US claimed
EP-2948454-A1 TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF Council of Scientific & Industrial Research An Indian registered body incorporated under the Registration of Societies Act (Act XXI of 1860) (IN) 2015-12-02 — — EP claimed
WO-2014115171-A1 TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-07-31 — — WO claimed
EP-0597022-B2 PROCESS FOR THE TEMPORARY DYEING OF KERATIN FIBRES INVOLVING AN INSOLUBLE PIGMENT OBTAINED BY THE OXIDATIVE POLYMERISATION OF INDOLE DERIVATIVES OREAL (FR) 1999-11-17 — — EP claimed
US-5874091-A PROTECTION OF SKIN AND HAIR AGAINST ULTRAVIOLET RADIATION AND FOR PIGMENTATION OF THE SKIN AND HAIR; HOMOGENEOUS AQUEOUS DISPERSION OF LAMELLAR AND ENCAPSULATING VESICLES; STORAGE STABILITY; STORING MELANIN PIGMENT IN THE STRATUM CORNEUM. L'OREAL (FR) 1999-02-23 — — US claimed
EP-0587837-B1 Cosmetic composition containing melanistic pigments in association with certain tocopherols, and method for protecting the skin, the hair, the mucous membranes and cosmetic compositions OREAL (FR) 1998-06-03 — — EP claimed
WO-1993017659-A1 COSMETIC COMPOSTION CONTAINING MELANISTIC PIGMENTS IN ASSOCIATION WITH CERTAIN TOCOPHEROLS, AND METHOD FOR PROTECTING THE SKIN, THE HAIR, THE MUCOUS MEMBRANES AND COSMETIC COMPOSITIONS L'OREAL (FR) 1993-09-16 — — WO claimed
EP-0544874-A1 METHOD FOR PREPARING SUBMICRON PARTICLES IN THE PRESENCE OF LIPID VESICLES, AND CORRESPONDING COMPOSITIONS L'OREAL (FR) 1993-06-09 — — EP claimed
US-5205837-A Formed in situ by oxidation of indole compound L'OREAL (FR) 1993-04-27 — — US claimed
WO-1993002655-A1 PROCESS FOR THE TEMPORARY DYEING OF KERATIN FIBRES INVOLVING AN INSOLUBLE PIGMENT OBTAINED BY THE OXIDATIVE POLYMERISATION OF INDOLE DERIVATIVES L'OREAL (FR) 1993-02-18 — — WO claimed
WO-1993000068-A1 METHOD FOR PREPARING SUBMICRON PARTICLES IN THE PRESENCE OF LIPID VESICLES, AND CORRESPONDING COMPOSITIONS L'OREAL (FR) 1993-01-07 — — WO claimed
EP-0518773-A1 Cosmetic composition containing a blend of metallic oxids nanopigments and melanic pigments L'OREAL (FR) 1992-12-16 — — EP claimed
EP-0504347-A1 COSMETIC COMPOSITION COMPRISING A DISPERSION OF LIPIDIC VESICLES AS WELL AS MELANIC PIGMENTS. OREAL (FR) 1992-09-23 — — EP claimed
WO-1992005761-A1 COSMETIC COMPOSITION COMPRISING A DISPERSION OF LIPIDIC VESICLES AS WELL AS MELANIC PIGMENTS L'OREAL (FR) 1992-04-16 — — WO claimed
EP-0467767-A1 Product based on flaky particles containing melanine pigment and process for their preparation L'OREAL (FR) 1992-01-22 — — EP claimed
US-5034015-A Fade resistant hair dyes with better coloring ability L'OREAL (FR) 1991-07-23 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353566-A1 TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF TPH2, IDO2, INMT KDM4E 862/4885ALDH1A1 2885/4885HPGD 2149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback